Investigating the utility of teletherapy in individuals with primary progressive aphasia.


Journal

Clinical interventions in aging
ISSN: 1178-1998
Titre abrégé: Clin Interv Aging
Pays: New Zealand
ID NLM: 101273480

Informations de publication

Date de publication:
2019
Historique:
entrez: 19 3 2019
pubmed: 19 3 2019
medline: 30 4 2019
Statut: epublish

Résumé

Primary progressive aphasia (PPA) is a neurodegenerative disorder characterized by progressive deterioration of speech and language. A growing body of research supports the utility of speech and language intervention in individuals with PPA, although access to these services remains limited. One potential means of increasing treatment accessibility is the delivery of treatment via telemedicine. Evidence supports the use of teletherapy in stroke-induced aphasia, but research examining the application of teletherapy in PPA is limited. In the current study, a non-randomized group comparison design was used to evaluate the feasibility and utility of treatment delivered via teletherapy relative to treatment administered in person for individuals with PPA. Two treatment protocols were administered as part of a larger study investigating treatment for speech and language deficits in PPA. Participants with semantic (n=10) and logopenic (n=11) PPA received lexical retrieval treatment and individuals with nonfluent/agrammatic PPA (n=10) received video-implemented script training for aphasia designed to promote speech production and fluency. Treatment was administered via teletherapy for approximately half of the participants receiving each intervention. Treatment outcomes and performance on standardized tests were assessed at pre-treatment and post-treatment, as well as 3, 6, and 12 months post-treatment. Overall, both treatment approaches resulted in significant gains for primary outcome measures. Critically, comparison of in-person and teletherapy groups revealed comparable outcomes. Generalization to untrained targets and tasks and maintenance of treatment-induced gains were also comparable for traditional vs teletherapy participants. Overall, treatment outcomes were largely equivalent for individuals receiving treatment via teletherapy vs traditional, in-person delivery. Results support the application of teletherapy for administering restitutive interventions to individuals with mild-to-moderate PPA. Potential implications for using teletherapy in the treatment of cognitive-linguistic and motoric impairments in other disorders and suggestions for administering treatment via telemedicine are discussed.

Identifiants

pubmed: 30880927
doi: 10.2147/CIA.S178878
pii: cia-14-453
pmc: PMC6394239
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

453-471

Subventions

Organisme : NIA NIH HHS
ID : P50 AG023501
Pays : United States
Organisme : NIDCD NIH HHS
ID : R03 DC013403
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG052943
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC016291
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS100440
Pays : United States
Organisme : NINDS NIH HHS
ID : R56 NS050915
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS050915
Pays : United States
Organisme : NIDCD NIH HHS
ID : K24 DC015544
Pays : United States

Déclaration de conflit d'intérêts

Disclosure The authors report no conflicts of interest in this work.

Références

J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Ann Neurol. 2008 Oct;64(4):388-401
pubmed: 18991338
Biomed Res Int. 2014;2014:706909
pubmed: 24829914
Behav Neurol. 2013;26(1-2):77-88
pubmed: 22713405
Int J Telerehabil. 2013 Jun 11;5(1):27-38
pubmed: 25945211
Neurology. 1998 Dec;51(6):1546-54
pubmed: 9855500
Brain. 2018 Jun 1;141(6):1799-1814
pubmed: 29718131
J Int Neuropsychol Soc. 2006 Nov;12(6):816-27
pubmed: 17064445
Neuropsychol Rehabil. 2012;22(2):187-214
pubmed: 22250922
J Speech Lang Hear Res. 2019 Aug 15;62(8):2723-2749
pubmed: 31390290
Neurology. 2005 Sep 27;65(6):887-91
pubmed: 16186529
Telemed J E Health. 2011 Dec;17(10):789-93
pubmed: 22023458
Int Rev Psychiatry. 2013 Apr;25(2):237-45
pubmed: 23611353
Am J Speech Lang Pathol. 2008 Feb;17(1):19-34
pubmed: 18230811
J Telemed Telecare. 2019 Feb;25(2):67-79
pubmed: 29117794
Curr Treat Options Neurol. 2015 Aug;17(8):362
pubmed: 26062526
Brain. 2010 Jul;133(Pt 7):2069-88
pubmed: 20542982
Curr Alzheimer Res. 2009 Aug;6(4):331-6
pubmed: 19689231
Brain Cogn. 2001 Jun-Jul;46(1-2):197-201
pubmed: 11527328
Aphasiology. 2017;31(9):1059-1077
pubmed: 29628604
Alzheimer Dis Assoc Disord. 2015 Jan-Mar;29(1):55-62
pubmed: 25037030
Clin Interv Aging. 2014 Sep 24;9:1605-11
pubmed: 25284993
J Am Med Dir Assoc. 2012 Jun;13(5):487.e19-24
pubmed: 22572552
Curr Opin Neurol. 2010 Dec;23(6):633-7
pubmed: 20852419
Int J Lang Commun Disord. 2011 Jan-Feb;46(1):1-16
pubmed: 21281410
Neurocase. 2001;7(2):173-84
pubmed: 11320164
J Int Neuropsychol Soc. 2009 Sep;15(5):645-9
pubmed: 19631024
Neurology. 2011 Mar 15;76(11):1006-14
pubmed: 21325651
Int J Telerehabil. 2011 Dec 20;3(2):3-10
pubmed: 25945183
Aphasiology. 2016 Apr 1;30(4):483-507
pubmed: 27087732
Telemed J E Health. 2004 Summer;10(2):147-54
pubmed: 15319044
Lancet Neurol. 2007 Nov;6(11):1004-14
pubmed: 17945154
Int J Speech Lang Pathol. 2016 Jun;18(3):299-314
pubmed: 27063691
Cortex. 2013 Jul-Aug;49(7):1823-32
pubmed: 23127420
Clin Interv Aging. 2006;1(4):467-71
pubmed: 18046923
Semin Speech Lang. 2012 Aug;33(3):243-57
pubmed: 22851346
Neuropsychology. 1999 Jul;13(3):359-80
pubmed: 10447298
Alzheimers Dement (N Y). 2016 Nov;2(4):213-221
pubmed: 28503656
Assessment. 2006 Dec;13(4):385-90
pubmed: 17050908
Cereb Cortex. 2003 Feb;13(2):170-7
pubmed: 12507948
Trends Cogn Sci. 2002 Feb 1;6(2):78-84
pubmed: 15866191
Am J Alzheimers Dis Other Demen. 2009 Oct-Nov;24(5):408-16
pubmed: 19700669
Neuropsychologia. 2011 Nov;49(13):3591-8
pubmed: 21939679
Aphasiology. 2015;29(9):1062-1081
pubmed: 26257456
Neuropsychologia. 2002;40(10):1715-28
pubmed: 11992659
Brain. 2012 Dec;135(Pt 12):3815-29
pubmed: 23250889
Clin Rehabil. 2016 Apr;30(4):359-73
pubmed: 25911523
Alzheimer Dis Assoc Disord. 2007 Apr-Jun;21(2):155-63
pubmed: 17545742
Neuropsychol Rehabil. 2006 Jun;16(3):241-56
pubmed: 16835150
Neuropsychol Rehabil. 2010 Jan;20(1):16-41
pubmed: 19504403
Semin Speech Lang. 2010 Feb;31(1):52-63
pubmed: 20221954
J Cogn Neurosci. 2016 Feb;28(2):210-22
pubmed: 26544920
Aphasiology. 2008 Jul 1;22(7-8):826-838
pubmed: 20862210
Am J Speech Lang Pathol. 2012 Aug;21(3):222-38
pubmed: 22442283
Brain Lang. 2013 Nov;127(2):145-56
pubmed: 23871425

Auteurs

Heather R Dial (HR)

Communication Sciences and Disorders, University of Texas at Austin, Austin, TX, USA, heather.raye.dial@gmail.com.

Holly A Hinshelwood (HA)

Speech Pathology, Wake Forest Baptist Health, Winston-Salem, NC, USA.

Stephanie M Grasso (SM)

Communication Sciences and Disorders, University of Texas at Austin, Austin, TX, USA, heather.raye.dial@gmail.com.

H Isabel Hubbard (HI)

Communication Sciences and Disorders, University of Alberta, Edmonton, AB, Canada.

Maria-Luisa Gorno-Tempini (ML)

Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.

Maya L Henry (ML)

Communication Sciences and Disorders, University of Texas at Austin, Austin, TX, USA, heather.raye.dial@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH